TY - JOUR
T1 - Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions
AU - Montone, Rocco Antonio
AU - Rinaldi, Riccardo
AU - Niccoli, Giampaolo
AU - Andò, Giuseppe
AU - Gragnano, Felice
AU - Piccolo, Raffaele
AU - Pelliccia, Francesco
AU - Moscarella, Elisabetta
AU - Zimarino, Marco
AU - Fabris, Enrico
AU - De Rosa, Salvatore
AU - Calabrò, Paolo
AU - Porto, Italo
AU - Burzotta, Francesco
AU - Grigioni, Francesco
AU - Barbato, Emanuele
AU - Chieffo, Alaide
AU - Capodanno, Davide
AU - Al-Lamee, Rasha
AU - Ford, Tom J.
AU - Brugaletta, Salvatore
AU - Indolfi, Ciro
AU - Sinagra, Gianfranco
AU - Perrone Filardi, Pasquale
AU - Crea, Filippo
PY - 2024
Y1 - 2024
N2 - : Angina pectoris may arise from obstructive coronary artery disease (CAD) or in the absence of significant CAD (ischemia with nonobstructed coronary arteries [INOCA]). Therapeutic strategies for patients with angina and obstructive CAD focus on reducing cardiovascular events and relieving symptoms, whereas in INOCA the focus shifts toward managing functional alterations of the coronary circulation. In obstructive CAD, coronary revascularization might improve angina status, although a significant percentage of patients present angina persistence or recurrence, suggesting the presence of functional mechanisms along with epicardial CAD. In patients with INOCA, performing a precise endotype diagnosis is crucial to allow a tailored therapy targeted toward the specific pathogenic mechanism. In this expert opinion paper, we review the evidence for the management of angina, highlighting the complementary role of coronary revascularization, optimal medical therapy, and lifestyle interventions and underscoring the importance of a personalized approach that targets the underlying pathobiology.
AB - : Angina pectoris may arise from obstructive coronary artery disease (CAD) or in the absence of significant CAD (ischemia with nonobstructed coronary arteries [INOCA]). Therapeutic strategies for patients with angina and obstructive CAD focus on reducing cardiovascular events and relieving symptoms, whereas in INOCA the focus shifts toward managing functional alterations of the coronary circulation. In obstructive CAD, coronary revascularization might improve angina status, although a significant percentage of patients present angina persistence or recurrence, suggesting the presence of functional mechanisms along with epicardial CAD. In patients with INOCA, performing a precise endotype diagnosis is crucial to allow a tailored therapy targeted toward the specific pathogenic mechanism. In this expert opinion paper, we review the evidence for the management of angina, highlighting the complementary role of coronary revascularization, optimal medical therapy, and lifestyle interventions and underscoring the importance of a personalized approach that targets the underlying pathobiology.
KW - INOCA
KW - chronic coronary syndromes
KW - ischemic heart disease
KW - personalized medicine
KW - therapy
KW - INOCA
KW - chronic coronary syndromes
KW - ischemic heart disease
KW - personalized medicine
KW - therapy
UR - http://hdl.handle.net/10807/288179
U2 - 10.1016/j.jacc.2024.06.015
DO - 10.1016/j.jacc.2024.06.015
M3 - Article
SN - 0735-1097
VL - 84
SP - N/A-N/A
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
ER -